https://www.selleckchem.com/pr....oducts/Temsirolimus.
The study design and protocol have been approved by the National Medical Ethics Committee of Slovenia (registration number 0120-573/2019/15). The study will be conducted in accordance with the Declaration of Helsinki. The results of the study will be published as peer-reviewed manuscripts and congress presentations, communicated with patients and the clinical community, and shared through posts on social media. The findings of the study will be disseminated among the national CR clinical community (CR centres, Slovenian association
Like
Comment
Share
